Childhood Disease Antigen Products

Microbix is at the leading edge of manufacturing native antigens for IVD industry leaders specializing in childhood disease immunological test development.

Your Trusted Childhood Disease Antigen Supplier

Microbix has constantly improved how we culture, isolate, and purify the viruses, with the result that many of the world’s largest diagnostic manufacturers have made our childhood disease antigens their #1 choice.

The childhood disease native antigens product panel includes rubella, varicella zoster, P3H3 cell extract, Epstein Barr viral capsid Ag (purified and concentrated), measles, and mumps. 

Proudly Supporting Over 100+ Customers with Leading  Diagnostic Solutions 

Testimonials

We considered other external quality controls but selected Microbix QAPs as the best solution to support assay optimization and to significantly simplify QC procedures with minimal to no pipetting steps. Microbix’s technical expertise, product design, performance, and superior customer service are impressive. We look forward to continuing our collaboration.

Robert Martinez, VP of Business Development & Scientific Affairs, BioGX

Setting the Gold Standard for Infectious Disease Diagnostic Standards

Decades of Diagnostics Excellence

For almost three decades, our antigens have been of the highest reliability and quality for diagnostic companies worldwide. 

Superior Quality Controls

Our antigen products are excellent positive quality controls for diagnostics assays.

Precise Antigen Solutions

Our extensive antigen panels are fit for any level of immunoassay you require. 

Download Our Full Product Catalogue 

News & Insights from Our Diagnostics Experts

  • Microbix Presenting at the 2024 Bloom Burton Conference

    MISSISSAUGA, CANADA, April 11, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Center, North Building, on April 16 and 17, 2024.…

Speak to a Childhood Disease Antigen Customer Service Representative

Let our knowledgeable experts help you secure your childhood disease antigen products today.







    Frequently Asked Questions

    What specific antigens or pathogens are covered by your childhood disease antigen products?

    Infectious diseases covered by our childhood disease antigen products include rubella, varicella zoster, P3H3 cell extract, Epstein Barr viral capsid Ag, measles, and mumps. 

    What is the source and purity of the childhood disease antigens you supply?

    Our childhood disease antigens are derived from natural sources. 

    Are the antigens provided in a ready-to-use form or as raw materials for further processing?

    This product is a ‘raw material’ for use by diagnostic manufacturers and other customer groups.

    What is the shelf life of your childhood disease antigen products?

    The shelf life of our childhood antigens is two years from the shipping date.

    Are these antigens suitable for diagnostic tests, vaccine development, or research purposes?

    These viral, bacterial, and parasitic antigen products are used in immunodiagnostic assays including ELISA, chemiluminescent automated immunoassays, immunohistochemistry, immunofluorescence, latex agglutination, rapid tests, and flow cytometry. Our childhood disease antigens are also used as external quality controls for diagnostic assays, basic and applied research in virology, microbiology, cell biology, immunology, and pathology, and for vaccine and antiviral research and development.

    Product NameEL Catalogue NumberProduct Description
    Rubella BR2SEL-05-15Description: The predominant form of the antigen is whole virions suspended in NTE with sucrose. The preparation is free of detergent. Residual non-viral protein may come from host tissue and culture medium.Strain: HPV-77Buffer: NTE buffer (Sodium chloride, TRIS and EDTA)
    Varicella-Zoster, Grade 2EL-03-02Description: The resulting antigen preparation contains a high concentration of virus and viral components as well as some cellular material suspended in EMEM with some serum proteins.Strain: VZ-10Buffer: EMEM
    P3H3 Cell ExtractEL-16-03Description: P3H3 Cell Extract contains a high concentration of Epstein-Barr Virus antigens, including VCA, EBNA, EA-D, and EA-R.Strain: P3H3 Human Burkitt’s Lymphoma cellsBuffer: Tris with NP40, sodium deoxycholate and PMSF
    EBV Purified Antigen ‘VCA’EL-16-06Description: This preparation contains more than 90% virus specific protein. The predominant form of the antigen is purified protein suspended in 20mM Tris-HCl with 3M MgCl,; pH 7.4. The preparation is free of detergent. Any residual non-viral protein comes from host tissue and culture medium.Strain: P3H3 cells infected with EBVBuffer: 20mM Tris-HCl with 3M MgCl2; pH 7.4
    EBV Purified Antigen ‘VCA’ (glycoprotein B, gB, BALF4) ConcentrateEL-16-07Description: This preparation contains more than 90% virus specific protein. The predominant form of the antigen is purified protein suspended in 20mM Tris-HCl with 3M MgCl2; pH 7.4. The preparation is free of detergent. Residual non-viral protein comes from host tissue and culture medium.Strain: P3H3 cells infected with EBVBuffer: 20mM Tris-HCl with 3M MgCl2; pH 7.4
    Measles, Grade 2EL-04-02Description: The resulting antigen preparation contains a high concentration of virus and viral components as well as some cellular material suspended in MEM.Strain: EdmonstonBuffer: MEM
    Mumps, Grade 2EL-06-02Description: The resulting antigen preparation contains a high concentration of virus and viral components as well as some cellular material suspended in 1969B.Strain: EndersBuffer: 1969B